BioMarin Pharmaceutical Competitors and Similar CompaniesClear all
BioMarin Pharmaceutical's competitors and similar companies include Biogen.
 BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 1997 | Founding Date 1978 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 3,0015% increase | Employees 7,605 |
Valuation ($) | Valuation ($) 13.3 b | Valuation ($) 26.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods $717.4m (FY, 2025) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit $2.5b (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income $348.9m (FY, 2025) | Net income $1.3b (FY, 2025) |
Operating ⚠ | ||
Phase I/II Trials Products | Phase I/II Trials Products 2 (FY, 2016) | Phase I/II Trials Products 1 (FY, 2022) |
Phase III Trials Products | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products 11 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company